Event
MarketKALSHIactive
MarketKALSHIactiveOther
When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List?
Part of: When will the FDA reclassify BPC-157 to Category 1?NoNo Price
99¢
|
VolTotal Volume
$0.00
|
Outcomes
2
Ends
Nov 8, 2026
in 7 monthsWhen will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List?
No
99¢
|
Vol
$0.00
|
Outcomes
2
Yes0.8¢
No99.2¢
Price History
When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List?
No historical data available
Price history will appear here when available
Resolution Information
Status
Active
Expected Resolution
November 08, 2026
3:00 PM GMT+0
Accuracy
100%
Resolved
8,750
Avg Time
< 24 hours
Disputes
0%
Resolution Criteria
If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Nov 1, 2026, then the market resolves to Yes. The Payout Criterion is satisfied by placement of BPC-157 in either Category 1 or Category 1 Bulk Drug Substances Under Evaluation on the 503A Bulk Drug Substances list, as either designation restores compounding eligibility. Removal from Category 2 alone, without placement in Category 1, does not satisfy the Payout Criterion. This market will close and expire early if the event occurs.
Market Still Active
This market has not yet resolved. Resolution will occur after the specified end date based on the criteria above.
Market Stats
Resolution Countdown
204 Days Left
November 08, 2026 • 3:00 PM
Last Updated
less than a minute ago